glp 1 gastroparesis treatment Researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity GLP-1 Intolerance and Endoscopic Sleeve

Novo Nordisk reserves the right to modify or cancel this savings program at any time

Per Trimi's published Refund Policy (last updated June 17, 2026): you need to stay on a continuous paid plan for six full months, take the medication as directed, log both a starting weight and a 6-month weight in the patient portal, and complete provider check-ins

Photo Credit: Jessica Kielman, Baldwin Publishing 40 mins This dish pairs juicy chicken breasts with fresh tomatoes and herbs for a bright, simple meal

This eliminates any financial disincentive to enroll patients with shorter monitoring needs

The REDEFINE 1 phase 3 trial showed CagriSema achieved 20.4% mean weight loss at 68 weeks in adults with obesity, with 60% of participants losing at least 20% of body weight ( [140] )